These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 14556012)

  • 1. Is preinfarction angina associated with better outcome after myocardial infarction?
    Górecki A; Chamiec T; Bednarz B; Maciejewski P; Łukaszewicz R; Ceremuzyński L
    Kardiol Pol; 2003 Jun; 58(6):457-68; discussion 467-8. PubMed ID: 14556012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
    Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
    J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preinfarction angina and myocardial preconditioning.
    Tomai F; Crea F; Chiariello L; Gioffrè PA
    Cardiologia; 1999 Nov; 44(11):963-7. PubMed ID: 10686771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy use for acute myocardial infarction and outcome in Qatar.
    Hadi HA; Al Suwaidi J; Bener A; Khinji A; Al Binali HA
    Int J Cardiol; 2005 Jul; 102(2):249-54. PubMed ID: 15982492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical presentation and pharmacological therapy in patients with cardiogenic pulmonary oedema.
    Fiutowski M; Waszyrowski T; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2004 Dec; 61(12):561-9; discussion 570. PubMed ID: 15815756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital and one-year outcomes of patients with high-risk acute myocardial infarction treated with thrombolysis or primary coronary angioplasty.
    Steffenino G; Santoro GM; Maras P; Mauri F; Ardissino D; Violini R; Chiarella F; Lucci D; Marini M; Baldasseroni S; Maggioni AP;
    Ital Heart J; 2004 Feb; 5(2):136-45. PubMed ID: 15086144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional capacity in patients after myocardial infarction dependent on treatment strategy in acute phase of disease].
    Lakusić N; Mahović D; Cerovec D; Baborski F; Majsec M
    Acta Med Croatica; 2005; 59(4):341-5. PubMed ID: 16334743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
    Danchin N; Blanchard D; Steg PG; Sauval P; Hanania G; Goldstein P; Cambou JP; Guéret P; Vaur L; Boutalbi Y; Genès N; Lablanche JM;
    Circulation; 2004 Oct; 110(14):1909-15. PubMed ID: 15451803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
    Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preinfarction angina does not alter infarct size and in hospital outcome after acute myocardial infarction with ST elevation.
    Psychari SN; Iliodromitis EK; Hamodraka E; Liakos G; Velissaridou A; Apostolou TS; Kremastinos DT
    Int J Cardiol; 2004 Apr; 94(2-3):187-91. PubMed ID: 15093979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
    Cambou JP; Simon T; Mulak G; Bataille V; Danchin N
    Arch Mal Coeur Vaiss; 2007; 100(6-7):524-34. PubMed ID: 17893635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of 24 h, nonfatal complications in patients with acute myocardial infarction receiving thrombolytic therapy by calculation of the ST segment deviation score.
    Schreiber W; Kittler H; Pieper O; Woisetschlaeger C; Laggner AN; Hirschl MM
    Can J Cardiol; 2003 Feb; 19(2):151-7. PubMed ID: 12601440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcome of diabetic patients with acute myocardial infarction. Data from the BLITZ-1 study.
    Casella G; Savonitto S; Chiarella F; Gonzini L; Di Chiara A; Bolognese L; De Servi S; Greco C; Zonzin P; Coccolini S; Maggioni AP; Boccanelli A;
    Ital Heart J; 2005 May; 6(5):374-83. PubMed ID: 15934409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.